Detailed Information
Cited 11 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Neoadjuvant giredestrant (GDC-9545) + palbociclib (palbo) vs anastrozole (A) plus palbo in post-menopausal women with oestrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2-eBC): Interim analysis of the randomised, open-label, phase II coopERA BC study
- Authors
- Hurvitz, SA[Hurvitz, S. A.]; Park, YH[Park, Y. H.]; Bardia, A[Bardia, A.]; Quiroga, V[Quiroga, V.]; Lopez-Valverde, V[Lopez-Valverde, V.]; Steinseifer, J[Steinseifer, J.]; Moore, HM[Moore, H. M.]; Spera, G[Spera, G.]; Xue, C[Xue, C.]; Fasching, PA[Fasching, P. A.]
- Issue Date
- 2021
- Publisher
- ELSEVIER
- Citation
- ANNALS OF ONCOLOGY, v.32, pp.S1285 - S1286
- Indexed
- SCIE
SCOPUS
- Journal Title
- ANNALS OF ONCOLOGY
- Volume
- 32
- Start Page
- S1285
- End Page
- S1286
- ISSN
- 0923-7534
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.